Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 7:2019:1825819.
doi: 10.1155/2019/1825819. eCollection 2019.

Neurodegeneration in Patients with Type 2 Diabetes Mellitus without Diabetic Retinopathy

Affiliations

Neurodegeneration in Patients with Type 2 Diabetes Mellitus without Diabetic Retinopathy

Elena Garcia-Martin et al. J Ophthalmol. .

Abstract

Purpose: To evaluate neurodegeneration in patients with type 2 diabetes mellitus (DM2) without diabetic retinopathy and to assess the possible role of systemic vascular complications in retinal changes.

Methods: Sixty eyes of 60 patients with DM2 and without any signs of diabetic retinopathy and 60 eyes of 60 healthy controls underwent retinal evaluation using Spectralis optical coherence tomography. Macular ganglion cell layer (GCL) and retinal nerve fiber layer (RNFL) were evaluated. Peripapillary RNFL thickness was assessed using Glaucoma and Axonal Analytics applications. Comparison between patients with the presence/absence of systemic vascular complications and different disease duration was made.

Results: Macular GCL was reduced in patients compared to controls (p < 0.001). Differences in the macular RNFL thickness were only observed in the outer inferior sector (p=0.033). A reduction in the peripapillary RNFL (average, inferior, and inferotemporal thickness, p < 0.05 for all three) was observed in patients using both applications. Patients with chronic systemic vascular complications presented a reduction in the temporal RNFL (p=0.019) compared to patients without complications. The superotemporal RNFL thickness was thinner in patients with longer disease duration.

Conclusions: Patients with type 2 DM without diabetic retinopathy and good metabolic control present neurodegeneration affecting neurons in the macular area and axons in different sectors of the optic disc. Systemic vascular complications contributed to further axonal damage in these patients, suggesting a possible role of subclinical ischaemia to retinal neurodegeneration in type 2 DM.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Santos A. R., Ribeiro L., Bandello F., et al. Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project. Diabetes. 2017;66(9):2503–2510. doi: 10.2337/db16-1453. - DOI - PubMed
    1. Shahidi A. M., Sampson G. P., Pritchard N., et al. Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy. Diabetic Medicine. 2012;29(7):e106–e111. doi: 10.1111/j.1464-5491.2012.03588.x. - DOI - PubMed
    1. Salvi L., Plateroti P., Balducci S., et al. Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: a sign of diabetic polyneuropathy, not retinopathy. Journal of Diabetes and Its Complications. 2016;30(3):469–476. doi: 10.1016/j.jdiacomp.2015.12.025. - DOI - PubMed
    1. Simó R., Hernández C. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends in Endocrinology & Metabolism. 2014;25(1):23–33. doi: 10.1016/j.tem.2013.09.005. - DOI - PubMed
    1. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(1):11–24.

LinkOut - more resources